Retinal ganglion cells and neuroprotection for glaucoma.
Neuroprotection is a therapeutic strategy directed at keeping retinal ganglion cells (RGCs) alive and functional. This article discusses three commonly asked questions about neuroprotection and attempts to answer them in the context of our current understanding of the pathophysiology of RGC loss in glaucomatous optic neuropathy.
Levin
Leonard A
LA
Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin 53792, USA.
D019610:Cytoprotection / Q000187:drug effects; D005901:Glaucoma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009901:Optic Nerve Diseases / Q000517:prevention & control; D012165:Retinal Ganglion Cells / Q000187:drug effects* / Q000502:physiology
D018696:Neuroprotective Agents